Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β 论文
2018Scientific Reports引用 360顶会
Alzheimer's disease research and treatmentsComputational Drug Discovery MethodsDrug Transport and Resistance Mechanisms
Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β · 相关文章
暂无数据